Zimmer Holdings, Inc., is offering us an advance preview of its future executive leadership team and organizational structure of what is to be called Zimmer Biomet, all assuming the deal closes without a hitch.
Back in April this year Zimmer and Biomet agreed to combine in a transaction valued at approximately $13.35 billion, a transaction that is expected to close in Q1 2015.
Just so we don’t forget about them in the meantime, Zimmer has unveiled its senior management team that will be charged with “establishing Zimmer Biomet as a global musculoskeletal healthcare leader by building upon the principles and practices that have made both companies so successful.”
The executive leadership team of the new Zimmer Biomet will comprise 12 executives reporting directly to David Dvorak, President and CEO of Zimmer, who will continue as President and CEO of the combined company. The team will be organized around three business units, three geographic regions and six functional areas.
The new team comprises four Biomet staffers and eight from Zimmer, about all of whom you can find out more from the Zimmer press release, here.
The respective companies will continue to operate under their current leadership structure and as two separate organizations until the closing of the transaction.
“These announcements mark important milestones that will help advance the effective integration of our two companies upon closing,” said Dvorak. “Zimmer and Biomet each have extraordinary talent across all levels, and we are confident that we have put in place a team and organizational structure to drive the combined company into this new chapter. In addition, becoming Zimmer Biomet brings together two well-respected and recognizable names in the industry that share a commitment to new innovations that enhance patient outcomes and improve quality of life.”
Source: Zimmer Holdings, Inc., PR Newswire